RNase L mediates the antiviral effect of interferon through a selective reduction in vital RNA during encephalomyocarditis virus infection

Journal of Virology

Volumn 72, Issue 4, 1998, Pages 2752-2759

  Li, Xiao Ling ^b   Blackford, John A ^b   Hassel, Bret A ^a,b  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; RIBONUCLEASE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; ENCEPHALOMYOCARDITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA DEGRADATION; RNA SYNTHESIS; VIRUS REPLICATION;

EID: 0031901636     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.4.2752-2759.1998     Document Type: Article

References (57)

1. Alarcon, B., H. Bugany, and L. Carrasco. 1984. pppA2′p5A′ blocks vesicular stomatitis virus replication in intact cells. J. Virol. 52:183-187.
2. Baglioni, C., A. DeBenedetti, and G. J. Williams. 1984. Cleavage of nascent reovirus mRNA by localized activation of the 2′-5′-oligoadenylate-dependent endoribonuclease. J. Virol. 52:865-871.
3. Baltimore, D., M. Girard, and J. E. Darnell. 1966. Aspects of synthesis of poliovirus RNA and the formation of virus particles. Virology 29:179-189.
4. Blostrom, D. C., S. Fahey, R. Kutny, B. D. Korand, and E. Knight, Jr. 1986. Molecular characterization of the interferon-induced 15-kDa protein. J. Biol. Chem. 261:8811-8816.
5. Brisbal, C., C. Martinand, M. Silhol, B. LeBleu, and Salehzada, T. 1995. Cloning and characterization of an RNase-L inhibitor: a new component of the interferon-regulated 2-5A pathway. J. Biol. Chem. 270:13308-13317.
6. Castelli, J. C., B. A. Hassel, K. A. Wood, X.-L. Li, K. Amemiya, M. C. Dalakas, P. F. Torrence, and R. J. Youle. 1997. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5 a system. J. Exp. Med 186:1-6.
7. Cayley, P. J., M. Knight, and I. M. Kerr. 1982. Virus-mediated inhibition of the ppp(A2′p)nA system and its prevention by interferon. Biochem. Biophys. Res. Commun. 104:376-382.
8. Chebath, J., P. Benech, M. Revel, and M. Vigneron. 1987. Constitutive expression of (2′-5′)oligo A synthetase confers resistance to picornavirus infection. Nature 330:587-588.
9. Clemmens, M. J., and B. R. G. Williams. 1978. Inhibition of cell-free protein synthesis by pppA2′p5′A2′p5′A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell 13:565-572.
10. Clouston, W. M., and J. F. R. Kerr. 1985. Apoptosis, lymphotoxicity and the containment of virus infections. Med. Hypotheses 18:399-404.
11. Collins, M. 1995. Potential roles of apoptosis in viral pathogenesis. Am. J. Crit. Care Med. 152:S20-S24.
12. Der, S. D., Y. L. Yang, C. Weissmann, and B. R. G. Williams. 1997. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:3279-3283.
13. Diaz-Guerra, M., C. Rivas, and M. Esteban. 1997. Inducible expression of the 2-5A synthetase/RNase-L system results in inhibition of vaccinia virus replication. Virology 227:220-228.
14. Dong, B., and R. H. Silverman. 1995. 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J. Biol. Chem. 270:4133-4137.
15. Dong, B., L. Xu, A. Zhou, B. A. Hassel, X. Lee, P. F. Torrence, and R. H. Silverman. 1994. Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase. J. Biol. Chem. 269:14153-14158.
16. Floyd-Smith, G., E. Slattery, and P. Lengyel. 1981. Interferon action: RNA cleavage pattern of a (2′-5′)oligoadenylate-dependent endonuclease. Science 212:1020-1032.
17. Fort, P. M., L. Marty, M. Piechaczyk, S. el Sabrouty, C. Dani, P. Janteur, and M. Blanchard. 1985. Various rat adult tissues express only one major species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1431-1442.
18. Greenberg, M. E., and J. G. Belasco. 1993. Control of the decay of labile protooncogene and cytokine mRNAs, p. 199-218. In J. G. Belasco and G. Brawerman (ed.), Control of messenger RNA stability. Academic Press, San Diego, Calif.
19. Gribaudo G., D. Lembo, G. Cavallo, S. Landolfo and P. Lengyel. 1991. Interferon action: binding of viral RNA to the 40-kilodalton 2′-5′-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J. Virol. 65:1748-1757.
20. Hahn, H., and A. C. Palmenberg. 1995. Encephalomyocarditis viruses with short poly(C) tracts are more virulent than their mengovirus counterparts. J. Virol. 69:2697-2699.
21. Hassel, B. A. Unpublished results.
22. Hassel, B. A., A. Zhou, C. Sotomayor, A. Maran, and R. H. Silverman. 1993. A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J. 12:3297-3304.
23. Houge, G., B. Robaye, T. S. Eikhom, J. Golstein, G. Mellgren, B. T. Gjertsen, M. Lanotte, and S. O. Doskeland. 1995. Fine mapping of 28S rRNA sites specifically cleaved in cells undergoing apoptosis. Mol. Cell. Biol. 15:2051-2062.
24. Hovanessian, A. G., R. E. Brown, and I. M. Kerr. 1977. Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells. Nature 268:537-539.
25. Isaacs, A., and J. Lindenmann. 1957. Virus interference. I. The interferon. Proc. R. Soc. Lond. B 147:258-267.
26. Johnston, M. I., and W. G. Hearl. 1987. Purification and characterization of a 2′-phosphodiesterase from bovine spleen. J. Biol. Chem. 262:8377-8382.
27. Kalvakolanu, D. V., and E. C. Borden. 1996. An overview of the interferon system: signal transduction and mechanisms of action. Cancer Investig. 14: 25-53.
28. Kerr, I. M., and R. E. Brown. 1978. pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc. Natl. Acad. Sci. USA 75:256-260.
29. Kibler, K. V., T. Shors, K. B. Perkins, C. C. Zeaman, M. P. Banaszak, J. Biesterfeldt, J. O. Langland, and B. L. Jacobs. 1997. Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J. Virol. 71:1992-2003.
30. Knight, M., P. J. Cayley, R. H. Silverman, D. H. Wreschner, C. S. Gilbert, R. E. Brown, and I. M. Kerr. 1980. Radioimmune, radiobinding and HPLC analysis of 2-5A and related oligonucleotides from intact cells. Nature 288: 189-192.
31. Krause, D., A. Panet, G. Arad, C. W. Dieffenbach, and R. H. Silverman. 1985. Independent regulation of ppp(A2′p)nA-dependent RNase in NIH3T3, clone 1 cells by growth arrest and interferon treatment. J. Biol. Chem. 260: 9501-9507.
32. Kumar, R., D. Choubey, P. Lengyel, and G. C. Sen. 1988. Studies on the role of the 2′-5′-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication. J. Virol. 62: 3175-3181.
33. Lee, S. B., and M. Esteban. 1994. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 199:491-496.
34. Liang, P., and A. B. Pardee. 1992. Differential display of eucaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967-971.
35. Marcu, K. B., L. J. Harris, L. W. Stanton, J. Erikson, R. Watt, and C. M. Croce. 1983. Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia. Proc. Natl. Acad. Sci. USA 80:519-523.
36. Merlin, G., J. Chebath, P. Benech, R. Metz, and M. Revel. 1983. Molecular cloning and sequence of partial cDNA for interferon-induced (2′-5′)oligo(A) synthetase mRNA from human cells. Proc. Natl. Acad. Sci. USA 80:4904-4908.
37. Meurs, E. F., Y. Watanabe, S. Kadereit, G. N. Barber, M. G. Katze, K. Chong, B. R. G. Williams, and A. G. Hovanessian. 1992. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J. Virol. 66:5805-5814.
38. Nilsen, T. W., and C. Baglioni. 1979. Mechanism for discrimination between viral and host mRNA in interferon-treated cells. Proc. Natl. Acad. Sci. USA 76:2600-2604.
39. Nilsen, T. W., P. A. Maroney, and C. Baglioni. 1981. Double-stranded RNA causes synthesis of 2′,5′-oligo(A) and degradation of messenger RNA in interferon-treated cells. J. Biol. Chem. 256:7806-7811.
40. Nilsen, T. W., P. A. Maroney, and C. Baglioni. 1982. Synthesis of (2′,5′)oligoadenylate and activation of an endoribonuclease in interferon-treated HeLa cells infected with reovirus. J. Virol. 42:1039-1045.
41. Pavlovic, J., A. Schroder, A. Blank, F. Pitossi, and P. Staeheli. 1993. Mx proteins: GTPases involved in the interferon-induced antiviral state. Ciba Found. Symp. 176:233-243.
42. Rysiecki, G., D. R. Gewert, and B. R. G. Williams. 1989. Constitutive expression of a 2′,5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J. Interferon Res. 9:649-657.
43. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
44. Saunders, M. E., D. R. Gewert, M. E. Tugwell, M. McMahon, and B. R. G. Williams. 1985. Human 2-5A synthetase: characterization of a novel cDNA and corresponding gene structure. EMBO J. 4:1761-1768.
45. Schindler, C., and J. E. Darnell. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621-651.
46. Sen, G. C., and P. Lengyel. 1992. The interferon system - a bird's eye view of its biochemistry. J. Biol. Chem. 267:5017-5020.
47. Silverman, R. H. 1997. 2-5A dependent RNase L: a regulated endoribo-nuclease in the interferon system, p. 515-551. In G. D'Alessio 2nd J. F. Riordan (ed.), Ribonucleases: structure and function. Academic Press, New York, N.Y.
48. Silverman, R. H., P. J. Cayley, M. Knight, C. S. Gilbert, and I. M. Kerr. 1982. Control of the ppp(A2′P)nA system in HeLa cells. Eur. J. Biochem. 124: 131-138.
49. nA activity in interferon-treated encephalomyocarditis virus-infected cells. J. Virol. 46:1051-1055.
50. Tada, H., O. Shiho, K. Kuroshima, M. Koyama, and K. Tsudamoto. 1986. An improved colorimetric assay for interleukin 2. J. Immunol. Methods 93: 57-165.
51. Troxler, M., D. Egger, T. Pfister, and K. Bienz. 1992. Intracellular localization of poliovirus RNA by in situ hybridization at the ultrastructural level using single-stranded riboprobes. Virology 191:687-697.
52. Watling, D., H. T. Serafinowska, C. B. Reese, and I. M. Kerr. 1985. Analogue inhibitor of 2-5A action: effect on the interferon-mediated inhibition of encephalomyocarditis virus replication. EMBO J. 4:431-436.
53. Williams, B. R. G. 1991. Transcriptional regulation of interferon-stimulated genes. Eur. J. Biochem. 200:1-11.
54. Williams, B. R. G., R. R. Golgher, R. E. Brown, C. S. Gilbert, and I. M. Kerr. 1979. Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells. Nature 282:582-586.
55. Wreschner, D. H., T. C. James, R. H. Silverman, and I. M. Kerr. 1981. Ribosomal RNA cleavage, nuclease activation and 2-5A (ppp(A2′p)nA) in interferon-treated cells. Nucleic Acids Res. 9:1571-1581.
56. nA-dependent ribonuclease. Nature 289:414-417.
57. Zhou, A., B. A. Hassel, and R. H. Silverman. 1993. Expression cloning of 2-5A dependent RNase: a uniquely regulated mediator of interferon action. Cell 72:1-20.